GAMMA Investing’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

GAMMA Investing’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-353	Closed	-$4.36K	–	3907
2024 Q4	$4.36K	Sell	353 -12	-3%	-$137	﹤0.01%	2967
2024 Q3	$4.15K	Buy	365 +100	+38%	+$1K	﹤0.01%	2818
2024 Q2	$1.89K	Buy	265 +107	+68%	+$818	﹤0.01%	2895
2024 Q1	$1.06K	Hold	158	–	–	﹤0.01%	2929
2023 Q4	$1.07K	Buy	+158	New	+$1.02K	﹤0.01%	2765

Other funds holding CDMO

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing's CDMO Position: Q1 2025 in Review

GAMMA Investing sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 353 shares — an estimated $4.36K sold.

GAMMA Investing first reported a position in CDMO in Q4 2023 and held it in 5 quarters. The position peaked at $4.36K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

GAMMA Investing reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
GAMMA Investing sold 353 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $4.36K.
GAMMA Investing first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
GAMMA Investing's Avid Bioservices, Inc. Common Stock position peaked at $4.36K in Q4 2024.
2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on GAMMA Investing's 13F filing for Q1 2025, filed 7 Apr 2025.